Showing results (1071-1080 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 20, 2022
Clonal Hematopoiesis in Late-Stage Non-Small-Cell Lung Cancer and Its Impact on Targeted Panel Next-Generation SequencingStephanie J Yaung, Frederike Fuhlbrück, Maureen Peterson, et al.
JCO Precision Oncology|January 20, 2022
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate CancerDonjete Simnica, Minke Smits, Edith Willscher, et al.
JCO Precision Oncology|December 29, 2021
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing StudyAlexander Pemov, Talia Wegman-Ostrosky, Jung Kim, et al.
JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.
JCO Precision Oncology|January 3, 2022
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility GenesAllison W Kurian, Paul Abrahamse, Kevin C Ward, et al.
JCO Precision Oncology|December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 SkippingXiuning Le, Lingzhi Hong, Chuck Hensel, et al.
JCO Precision Oncology|January 13, 2022
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide TherapyAbhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths, et al.
JCO Precision Oncology|November 22, 2021
Lessons Learned From Implementing a Novel Bayesian Adaptive Dose-Finding Design in Advanced Pancreatic CancerRebecca S S Tidwell, Peter F Thall, Ying Yuan
JCO Precision Oncology|November 25, 2021
Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only SequencingNahed Jalloul, Israel Gomy, Samantha Stokes, et al.
JCO Precision Oncology|October 20, 2022
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA SamplesHatim Husain, Dean C Pavlick, Bernard J Fendler, et al.
Pageof 140